On December 27th, Simcere Pharma (02096) spent HKD 8,950,100 to repurchase 1,321,000 shares.

27/12/2024

GMT Eight

SIMCERE PHARMA (02096) announced that on December 27, 2024, they spent 8,950,100 Hong Kong dollars to repurchase 1,321,000 shares, with a repurchase price of 6.7-6.8547 Hong Kong dollars per share.

Shareholder Li Jian of Hangzhou Huaxing Chuangye Communication Technology (300025.SZ) intends to transfer 5% of the shares to Sanwei in Chengdu.

NEWBORNTOWN (09911) appoints Chen Sichao as an independent non-executive director.

Contact: contact@gmteight.com

On December 27th, Simcere Pharma (02096) spent HKD 8,950,100 to repurchase 1,321,000 shares.

RECOMMEND

US Stock Market Move | The previously announced weight loss drug Cagrisema data caused Novo Nordisk A/S Sponsored ADR Class B (NVO.US) to fall more than 8%.

Three directors and executives of Asia Cuanon Technology (603378.SH) plan to reduce their holdings by a total of no more than 4.038 million shares.

JH EDUCATION (01935): Zhengzhou Institute of Economics and Trade has signed a construction engineering contract with Henan Xianrui Construction Engineering.